Clinical trial
Multicenter, Evaluator-blinded, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLITE™ XC Injectable Gel for Improvement in Neck Appearance
NCT05316233 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Evaluator-blinded, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLITE™ XC Injectable Gel for Improvement in Neck Appearance
- Lead sponsor
- AbbVie
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 2, 2022
- Completion date
- September 12, 2024
- Enrollment
- 159 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
neck lines